1. Home
  2. BBY vs ILMN Comparison

BBY vs ILMN Comparison

Compare BBY & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Best Buy Co. Inc.

BBY

Best Buy Co. Inc.

HOLD

Current Price

$74.19

Market Cap

15.6B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$128.90

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBY
ILMN
Founded
1966
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6B
18.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
BBY
ILMN
Price
$74.19
$128.90
Analyst Decision
Buy
Hold
Analyst Count
19
15
Target Price
$84.24
$114.93
AVG Volume (30 Days)
4.1M
1.5M
Earning Date
11-25-2025
10-30-2025
Dividend Yield
5.12%
N/A
EPS Growth
N/A
N/A
EPS
3.02
4.46
Revenue
$41,825,000,000.00
$4,288,000,000.00
Revenue This Year
$1.77
N/A
Revenue Next Year
$1.32
$2.08
P/E Ratio
$24.54
$28.91
Revenue Growth
N/A
N/A
52 Week Low
$54.99
$68.70
52 Week High
$91.68
$153.06

Technical Indicators

Market Signals
Indicator
BBY
ILMN
Relative Strength Index (RSI) 40.86 66.70
Support Level $74.24 $124.27
Resistance Level $83.67 $129.72
Average True Range (ATR) 2.59 3.90
MACD -0.30 -0.41
Stochastic Oscillator 11.07 77.82

Price Performance

Historical Comparison
BBY
ILMN

About BBY Best Buy Co. Inc.

With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: